FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Aortic Valve, Prosthesis, Percutaneously Delivered

PMA: P130021 · Supplement: S117 · Decision Jun 8, 2022
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Trade Name
Medtronic Evolut FX Delivery Catheter System
PMA Number
P130021
Supplement Number
S117
Device Class
FDA Class 3
Product Code
NPT
Generic Name
Aortic valve, prosthesis, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
June 8, 2022
Date Received
May 31, 2022
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Implementation of various improvements to the manufacturing process of the Evolut FX Delivery Catheter System (DCS) stability member bond.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPT Aortic Valve, Prosthesis, Percutaneously Delivered